Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
暂无分享,去创建一个
[1] H. Fukushima,et al. Prognostic Value of Albumin/Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy. , 2018, Anticancer research.
[2] S. Barni,et al. Prognostic Factors of Overall Survival in Upper Urinary Tract Carcinoma: A Systematic Review and Meta-analysis. , 2017, Urology.
[3] Y. Lotan,et al. Prognostic serum markers in patients with high-grade upper tract urothelial carcinoma. , 2016, Urologic oncology.
[4] J. Yun,et al. Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma. , 2016, Clinical genitourinary cancer.
[5] S. Barni,et al. Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies , 2015, Acta oncologica.
[6] Qing Yang,et al. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis , 2015, Scientific Reports.
[7] K. Moon,et al. Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma , 2015, World Journal of Urology.
[8] W. Zhan,et al. The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer , 2014, Disease markers.
[9] K. Bensalah,et al. Predictors of survival in patients with disease recurrence after radical nephroureterectomy , 2014, BJU international.
[10] M. Djokic,et al. The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma , 2014, International Urology and Nephrology.
[11] C. Kwak,et al. Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. , 2013, European journal of cancer.
[12] M. Babjuk,et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. , 2013, European urology.
[13] Y. Kanai,et al. Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy. , 2013, The Journal of urology.
[14] F. Saint,et al. Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival , 2012, Annals of Surgical Oncology.
[15] R. Blasberg,et al. Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype , 2011, Clinical Cancer Research.
[16] A. Cheung,et al. Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. , 2011, Kidney international.
[17] K. Bensalah,et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[19] Huasheng Lu,et al. Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.
[20] Q. Lu,et al. Diagnosis of primary liver cancer using lectin affinity chromatography of serum alkaline phosphatase. , 1997, Journal of experimental & clinical cancer research : CR.
[21] M. Babjuk,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. , 2015, European urology.
[22] K. Nakagawa,et al. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. , 2014, European urology.
[23] C. Porter,et al. Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review. , 2002, American journal of clinical pathology.